| Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer V Piñol, A Castells, M Andreu, S Castellví-Bel, C Alenda, X Llor, ... Jama 293 (16), 1986-1994, 2005 | 629 | 2005 |
| Germline RAD51C mutations confer susceptibility to ovarian cancer C Loveday, C Turnbull, E Ruark, RMM Xicola, E Ramsay, D Hughes, ... Nature genetics 44 (5), 475-476, 2012 | 292 | 2012 |
| Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer R Jover, P Zapater, A Castells, X Llor, M Andreu, J Cubiella, V Piñol, ... Gut 55 (6), 848-855, 2006 | 264 | 2006 |
| Risk of cancer in cases of suspected lynch syndrome without germline mutation M Rodríguez–Soler, L Pérez–Carbonell, C Guarinos, P Zapater, ... Gastroenterology 144 (5), 926-932. e1, 2013 | 254 | 2013 |
| The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status R Jover, P Zapater, A Castells, X Llor, M Andreu, J Cubiella, F Balaguer, ... European journal of cancer 45 (3), 365-373, 2009 | 238 | 2009 |
| 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer R Jover, TP Nguyen, L Pérez–Carbonell, P Zapater, A Payá, C Alenda, ... Gastroenterology 140 (4), 1174-1181, 2011 | 227 | 2011 |
| Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer L Pérez-Carbonell, C Ruiz-Ponte, C Guarinos, C Alenda, A Payá, A Brea, ... Gut 61 (6), 865-872, 2012 | 213 | 2012 |
| Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study F Balaguer, S Castellví–Bel, A Castells, M Andreu, J Muñoz, JP Gisbert, ... Clinical Gastroenterology and Hepatology 5 (3), 379-387, 2007 | 197 | 2007 |
| Performance of different microsatellite marker panels for detection of mismatch repair–deficient colorectal tumors RM Xicola, X Llor, E Pons, A Castells, C Alenda, V Piñol, M Andreu, ... Journal of the national cancer institute 99 (3), 244-252, 2007 | 197 | 2007 |
| Race-dependent association of sulfidogenic bacteria with colorectal cancer C Yazici, PG Wolf, H Kim, TWL Cross, K Vermillion, T Carroll, GJ Augustus, ... Gut 66 (11), 1983-1994, 2017 | 178 | 2017 |
| Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway X Llor, E Pons, RM Xicola, A Castells, C Alenda, V Pinol, M Andreu, ... Clinical cancer research 11 (20), 7304-7310, 2005 | 149 | 2005 |
| Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency A Goel, RM Xicola, TP Nguyen, BJ Doyle, VR Sohn, P Bandipalliam, ... Gastroenterology 138 (5), 1854-1862. e1, 2010 | 136 | 2010 |
| Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer L Bujanda, C Sarasqueta, L Zubiaurre, A Cosme, C Munoz, A Sanchez, ... Gut 56 (12), 1714-1718, 2007 | 134 | 2007 |
| A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening X Bessa, B Ballesté, M Andreu, A Castells, B Bellosillo, F Balaguer, ... Clinical Gastroenterology and Hepatology 6 (2), 206-214, 2008 | 105 | 2008 |
| Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria RM Xicola, S Li, N Rodriguez, P Reinecke, R Karam, V Speare, MH Black, ... Journal of medical genetics 56 (12), 838-843, 2019 | 102 | 2019 |
| Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors B Ballesté, X Bessa, V Pinol, S Castellví-Bel, A Castells, C Alenda, A Paya, ... Diseases of the colon & rectum 50 (7), 971-980, 2007 | 89 | 2007 |
| A meta-analysis of MSI frequency and race in colorectal cancer H Ashktorab, S Ahuja, L Kannan, X Llor, NA Ellis, RM Xicola, AO Laiyemo, ... Oncotarget 7 (23), 34546, 2016 | 86 | 2016 |
| Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic A Giros, M Grzybowski, VR Sohn, E Pons, J Fernandez-Morales, ... Cancer prevention research 2 (8), 732-742, 2009 | 78 | 2009 |
| A genome-wide association study identifies susceptibility loci for Wilms tumor C Turnbull, ER Perdeaux, D Pernet, A Naranjo, A Renwick, S Seal, ... Nature genetics 44 (6), 681-684, 2012 | 74 | 2012 |
| Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration C Fernandez-Rozadilla, JB Cazier, V Moreno, M Crous-Bou, E Guinó, ... The pharmacogenomics journal 13 (3), 209-217, 2013 | 67 | 2013 |
